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Mutation-induced aggregation of the dimeric enzyme Cu, Zn su-
peroxide dismutase 1 (SOD1) has been implicated in the familial
form of the disease amyotrophic lateral sclerosis, but the mecha-
nism of aggregation is not known. Here, we show that in vitro
SOD1 aggregation is a multistep reaction that minimally consists of
dimer dissociation, metal loss from the monomers, and oligomer-












where Dholo, Mholo, Mapo, and A are the holo-dimer, holo-monomer,
apo-monomer, and aggregate, respectively. Under aggregation-
promoting conditions (pH 3.5), the rate and equilibrium constants
corresponding to each step are: (i) dimer dissociation, Kd 1 M;
koff  1  103 s1, kon 1  103 M1s1; (ii) metal loss, Km 0.1
M, km
 1  103 s1, km
 1  104 M1s1; and (iii) assembly
(rate-limiting step), kagg 1  103 M1s1. In contrast, under
near-physiological conditions (pH 7.8), where aggregation is dras-
tically reduced, dimer dissociation is less thermodynamically fa-
vorable: Kd  0.1 nM, and extremely slow: koff 3  105 s1, kon
3  105 M1s1. Our results suggest that familial amyotrophic
lateral sclerosis-linked SOD1 aggregation occurs by a mutation-
induced increase in dimer dissociation andor increase in apo-
monomer formation.
Amyotrophic lateral sclerosis (ALS) involves selective motorneuron death in the brain and spinal cord (1–6), initiating a
progressive paralysis in midlife. Point mutations in the cytoplasmic
homodimeric enzyme Cu, Zn superoxide dismutase 1 [SOD1,
molecular mass (Mm)  32 kDa] were identified as the primary
cause of 20% cases of the familial form of ALS (FALS) (7, 8) in
contrast with the sporadic form. Approximately 90 distinct FALS
mutations are known (9). The toxic gain-of-function of the mutants
is believed to be associated with either intracellular misfolding and
aggregation or oxidative damage caused by mutant SOD1-
catalyzed aberrant reactions, although the two scenarios may not be
mutually exclusive (10, 11). The aggregation hypothesis is supported
by the observations that in both mice and cell culture models death
of motor neurons is preceded by formation of cytoplasmic aggre-
gates containing mutant SOD1 (12–15), SOD1 knockout mice do
not develop motor neuron disease (16), and even Cu-depleted
SOD1 mutants cause the disease in mice (17). Although aggrega-
tion of SOD1 has also been found in some cases of sporadic ALS
(18–20), the sporadic disease is believed to have a different
molecular basis (1). FALS and SOD1-linked sporadic ALS may
belong to the general class of protein conformational disorders in
which perturbation of protein folding leads to a relatively higher
population of misfolded or partially folded (21) protein molecules,
which then aggregate into regular (22) structured fibrils. Toxicity
may arise because of the saturation of the cellular chaperone
machinery by misfolded or aggregated SOD1 molecules (23).
ALS is an age-related disease occurring in midlife or later, and
it is not surprising that the in vitro aggregation of SOD1 solutions
under physiological conditions is slow. Therefore, it is common to
study SOD1 aggregation by perturbing the environmental condi-
tions, lowering the pH to 3.5 (24), adding mild denaturants such as
trifluoroethanol, or using heat treatment (25), such that disease-like
aggregates can be detected on experimental time scales. Aggrega-
tion-prone FALS mutations andor loss of metals also decrease
SOD1 stability (26, 27), indicating that exposure to nonphysiologi-
cal conditions, such as low pH, mimics the effect of mutation by
similarly lowering the barrier for SOD1 aggregation. Although the
rate of aggregation can be enhanced in vitro, the molecular mech-
anism of SOD1 aggregation is not well understood.
We show here that the relatively rapid aggregation of SOD1 that
results from perturbations in the environmental conditions occurs
because these conditions promote dimer dissociation andor the
loss of metals and that the thus-formed apo-monomers undergo
multimeric assembly. We propose that this same reaction path holds
for some or all FALS mutant forms of SOD1 and that increased
aggregation results from perturbation of one or more of the steps
in the pathway demonstrated here: dimer dissociation, metal loss
from monomers, and aggregation of apo-monomers.
Methods
Protein and Buffers. Bovine and human erythrocyte Cu, Zn SOD
(EC 1.15.1.1) were obtained from Sigma. Protein concentration was
measured spectrophotometrically at 258 nm for the bovine enzyme
(28). Buffers used for surface plasmon resonance (SPR) contained
50 mM phosphate and 150 mM NaCl at pH 12.50, 11.85, 10.8, 7.8,
6.6, 5.8, and 4.8; reactions at pH 3.5, 3.0, and 2.7 contained 100 mM
acetate and 150 mM NaCl.
Biotinylation Reaction. Biotinylated SOD1 was prepared at low
stoichiometry (1 mol equivalent of biotinylating agentSOD1
dimer) for SPR studies and high (10-fold excess of biotinylating
agentSOD1 dimer) stoichiometry for size-exclusion chromatog-
raphy (SEC) studies as described (29). Biotinylated SOD1 was
found to be fully active after biotinylation (ref. 30 and data not
shown) and had identical chromatographic properties compared
with the unmodified protein (Fig. 5, which is published as support-
ing information on the PNAS web site).
Analytical Ultracentrifugation (AUC). The Kd for SOD1 dimer disso-
ciation was determined by using a Beckman-XLA ultracentrifuge at
a speed of 20,644  g at 4°C or 25°C by using a An-60Ti rotor.
Radial UV absorbance (258 nm) was monitored every 2 h in cells
with a path length of 12 mm. One blank buffer sample was used for
each protein sample to obtain baselines. A total of seven scans were
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obtained for each sample and the corresponding blank cell to reach
equilibrium, followed by overspinning at 163,296  g to obtain
another estimate of baseline absorbance (typically 0.01 units). The
UV-absorbance profiles were superimposed to ensure equilibrium
and analyzed for residuals, and the equilibrium profiles were fit to
the Lambert equation to obtain estimates of Kd and apparent Mm.
SEC. SEC was performed with a Pharmacia Akta chromatography
system by using an Amersham Pharmacia-Pharmacia Superdex HR
1030 column with a 200-l injection loop, total volume of 23.56 ml,
and a void volume estimate of 7.8 ml, working at 5°C. The column
flow rate was 0.45 mlmin. Fractions (150–250 l) were collected
in glass tubes, and these were analyzed immediately after complet-
ing the chromatogram. In reactions with low (nanomolar) SOD1
concentrations, the reaction mixture and the column buffer con-
tained BSA at 10 mgl to prevent nonspecific binding of SOD1 to
test tubes and the column matrix. UV absorbance was monitored
spectrophotometrically at 254 nm.
Dot Blotting. Column fractions were analyzed by a dot-blot assay,
with Avidin-AP, as described (29) andor by immunostaining with
anti-SOD1 antibody (Supporting Text, which is published as sup-
porting information on the PNAS web site).
SPR Measurements. Plasmon resonance sensor chips, precoated
with strepavidin, were obtained from Biacore (Piscataway, NJ)
and used with a Biacore model 2000 instrument. The chips were
pretreated with NaOH50 mM NaCl (pH 12.7) before biotin-
SOD1 was immobilized. The volume of each flow cell (four per
chip) was 7 nl, and a buffer flow of 2 l per min was used at 25°C.
Low stoichiometry (1 biotindimer) biotin-SOD1 was immo-
bilized on one flow cell surface such that an increase of 3,000
resonance units resulted. After binding was complete, SOD1
dimer dissociation was induced with protein-free buffer. A small
correction for the signal drift was applied by using the signal
from the flow cells that had not received biotin-SOD1 but
received protein-free buffer. To obtain the pH dependence of
the rate constant, the zero-order dissociation reaction was
followed sequentially with increasing or decreasing pH, starting
at pH 7.8.
Results













where Dholo, Mholo, Mapo, and A are the holo-dimer, holo-monomer,
Zn-free monomer (31), and aggregate, respectively. Next, we show
that: (i) the Kd and koff for SOD1 dimer dissociation are enhanced
under aggregation-promoting conditions; and (ii) aggregation re-
quires dissociation of the SOD1 dimer to monomers and a subse-
quent loss of metals. Based on the observed aggregation kinetics,
we calculated the rate and equilibrium constants for each step in the
reaction sequence.
The Kd for SOD1 Dimer Dissociation Is 6  103-Fold Higher Under
Aggregation-Enhancing Conditions than Under Near-Physiological
Conditions. The Kd and Mm of SOD1 under aggregation-enhancing
conditions were determined by using AUC (Table 1), fitting the
absorbance profiles to a dimer-monomer equilibrium. SOD1 (30
M) was entirely dimeric (apparent Mm  36 kDa) at pH 7.8 and
was entirely monomeric (apparent Mm  16 kDa) when metals were
chelated by incubation with 10 mM EDTA at pH 3.5. A Kd of 1
M was calculated for the dimer-monomer equilibrium by a
combined fit to the AUC profiles of 30, 20, and 10 M SOD1. Thus,
at pH 3.5, where aggregation was previously observed (24), 30 M
SOD1 was 84% dimer and 16% monomer. In contrast, 30 M
SOD1 was 100% dimer under near-physiological conditions (pH
7.8), where aggregation does not occur.
The Kd for SOD1 dimer dissociation at pH 7.8 could not be
measured by AUC because the optical system used to detect the
protein is limited to micromolar concentrations. However, nM
SOD1 concentrations could be analyzed by using SEC and a
dot-blot assay. Based on the calibration of the Superdex HR 1030
column (Fig. 1A), the SOD1 dimer and monomer were expected to
elute at 15.5 and 17.0 ml, respectively; SOD1 at 30 M in pH 7.8
buffer eluted as 100% dimer at 15.6 ml (Fig. 1B), in accord with
AUC measurements (Table 1). The Kd at pH 7.8 was estimated with
5 nM SOD1, which gave column fractions at the limit of detection.
The bulk of the protein eluted as a dimer at 15.3 ml with a small
reproducible monomer peak at 16.8 ml, comprising 20% of the
total protein (Fig. 1C). The dimer and monomer were expected to
elute as distinct peaks because they were in slow equilibrium: the
half-time for dimer dissociation was 6 h at pH 7.8 and 25°C (see
below), whereas the time required for chromatographic separation
was 10 min at 5°C. A Kd of 0.16 nM was calculated from a
double-Gaussian least-square fit to the data and is in reasonable
agreement with the Kd of 1 nM estimated from the unfolding
studies of human SOD1 (32). Thus, the Kd of 1  106 M at pH
3.5 is larger than the Kd of 1.6  1010 M at pH 7.8 by a factor
Table 1. Measurement of the Kd for SOD1 dimer dissociation by
using AUC
Conditions Mm, Da Comment
30 M, pH 7.8 36,180 Dimeric
30 M, pH 3.5  EDTA (4°C)* 16,417 Monomeric
30 M, pH 3.5 29,402 Kd  0.90 M
20 M, pH 3.5 27,481 Kd  1.3 M
10 M, pH 3.5 27,425 Kd  0.82 M
30 M, pH 3.5  24 h 30,269 Kd  1.29 M
10 M, pH 3.5  24 h 29,969 Kd  1.29 M
*Low temperature was used with EDTA to avoid aggregation of the apo-
monomer.
Fig. 1. Size-exclusion profiles of SOD1 at pH 7.8. (A) The calibration curve for
the column obtained by using globular protein standards at pH 7.8 was log
(Mm1,000)  4.56–1.526(VeV0), where Ve is the elution volume and V0 is the
void volume (7.8 ml) of the column. SOD dimer (32 kDa) and monomer (16 kDa)
were expected to elute at 15.5 and 17.0 ml, respectively. (B) Elution profile at
30 M: SOD1 elutes at 15.6 ml and thus is dimeric. (C) Immunostaining dot-blot
profile of a 5 nM SOD1 sample after 24 h of incubation. The peaks are Gaussian
fits and correspond to the dimer and monomer.







of 6  103. This corresponds to a large (5.2 kcalmol) reduction
in dimer stability, indicating that a higher fraction of SOD1 is
monomeric under aggregation-enhancing conditions than under
near-physiological conditions.
Because identical Mm estimates were obtained for 10 M SOD1
at pH 3.5 with and without a 24-h incubation (Table 1) dimer
dissociation is presumably reversible, and the irreversible (33, 34)
step in the aggregation lies downstream of dimer dissociation. The
reversibility of dimer dissociation under aggregation-promoting
conditions was directly demonstrated by SEC (Fig. 6, which is
published as supporting information on the PNAS web site, and
Supporting Text).
The koff for SOD1 Dimer Dissociation Is 30-Fold Higher Under Aggre-
gation-Enhancing Conditions than Under Near-Physiological Condi-
tions. Having determined that the Kd for dimer dissociation was
enhanced 6,000-fold at pH 3.5, we used SPR to determine the
kinetics of dimer dissociation. SOD1, biotinylated at low stoichi-
ometry (1 biotinSOD1 dimer), was immobilized on a strepavi-
din-coated gold surface. As shown in Fig. 2A, the biotinylated dimer
has one subunit bound to strepavidin, and the nonbiotinylated
subunit is progressively lost by flowing SOD1-free buffer through
the flow cell, leading to a SPR signal decrease of 50%. The
dissociation is made irreversible by a 2,000 nlmin flow of protein-
free buffer through the 7-nl flow cell. The rate constant for
dissociation koff was determined by an exponential fit to the entire
signal decay corresponding to a first-order reaction (Fig. 2 B and C)
or by a linear fit to the initial signal decay corresponding to a
zero-order reaction (Fig. 2D). The dissociation at pH 3.5 had a
half-time of 600 s (koff  1.0  103 s1; Fig. 2B), whereas the
dissociation at pH 7.8 had a half-time of 6 h (koff  3.1  105
s1; Fig. 2C). Therefore, under conditions where aggregation was
observed (pH 3.5), the rate of dimer dissociation is 30-fold faster
than under near-physiological conditions. This result corresponds
to an 2.0 kcalmol reduction in the energy barrier for dissociation.
SOD1 Dimer Dissociation May Be Induced by the Disruption of Salt
Linkages. The dramatic increase in koff at pH 3.5 suggests that
insights into the forces stabilizing the SOD1 dimer could be
obtained from the pH dependence of the reaction. The koff in-
creased sharply on the acidic and basic ends of the pH range from
2.5 to 12.7 (Fig. 2 D and E). In the simplest unified model to account
for this effect, dimer dissociation is linked with the titration of
carboxyl (Asp, Glu) and amine (Lys, Arg) groups forming a salt
linkage. At any given pH, the observed koff reflects the dissociation
of three subpopulations of the SOD1 dimer, in which the salt
linkage is: (i) intact, (ii) disrupted because of the protonation of the
carboxylic acid, and (iii) disrupted because of the deprotonation of
the amine. The species from these subpopulations have intrinsic
dissociation rate constants, kind, kacid, and kbasic, respectively, which
are weighted by their pH-dependent population size, so that the
observed koff is:
koff
obs  kacid HH  Ka  kbasic KbKb  H  k ind,
[2]
where Ka and Kb are the equilibrium constants for the deprotona-
tion of the carboxyl and amine groups involved. The first and the
second terms dominate at low and high pH, respectively, and the
rate is pH-independent at intermediate pH values. According to
Eq. 2, in the low pH regime the titration-induced increase in log koff
obs
is predicted to have a slope of 1 when pH  pKa. Similarly, a
slope of 1 is predicted for the corresponding increase in the high pH
regime when pH 		 pKb, and such increases were observed at both
low and high pH (Fig. 2E). The apparent pKa and pKb values of
	2.5 and 12.5, presumably correspond to carboxyl (Asp; free
pK  3.86) and amine (Arg; free pK  12.48) groups forming a
highly stabilizing salt linkage. The linkage of the protonation of the
carboxylic acid and the deprotonation of the amine to the dimer
dissociation leads to the abnormal apparent pK values. The 100-fold
change in the observed koff in the intermediate pH range from 4.8
to 10.8 is indicative of other titrations, possibly of charged amino
acid side chains, which may not form salt linkages, so that they have
a smaller effect on the rate kind.
Human SOD1, which is highly homologous (82% sequence
identity) to the bovine enzyme, exhibits a similar pH dependence
of dimer dissociation. The koff values were similar at pH 6.6 (Fig. 2D
Inset) and at pH 7.8: 2.74  105 s1 for human SOD1 (data not
shown) and 3.13  105 s1 for bovine SOD1 (Fig. 2B).
Interestingly, there are no salt linkages on the dimer interface of
either bovine or human SOD1 so that the enhanced dissociation
rate is caused indirectly by the titration of a salt linkage that is not
in the proximity of the dimer interface. The Arg-79–Asp-101
interaction was identified as a candidate for such a salt linkage (Fig.
7, which is published as supporting information on the PNAS web
site, and Supporting Text). This salt-linkage mechanism provides a
unified framework that accounts for the steep pH dependence of
the reaction at low and high pH and is consistent with the previous
finding that charge–charge interactions in SOD1 contribute sub-
stantially to its stability and folding kinetics (21). An alternative
mechanism in which ionization of surface-exposed residue(s) dra-
matically influences dimer stability is less likely because it does not
simultaneously predict behavior at extremes of pH and the modest
pH dependence of the rate at intermediate pH values.
Rapid Oligomerization of SOD1 Occurs Under Conditions Where It Is
Monomeric. To test directly whether SOD1 monomer or dimer is the
aggregation-competent species, we characterized the initial phase
Fig. 2. The dimer dissociation rates of SOD1 measured by SPR. (A) Scheme for
SPR measurement of SOD1 dimer dissociation rate. The rate constant at pH 3.5
was calculated as 1.07  103 s1 (B) and 3.13  105 s1 at pH 7.8 (C), by fitting
to a single exponential (dotted lines). The initial rate was followed in the pH
range from 2.5 to 12.7. (D) For dissociation at pH 6.6, the rate constant was
found to be 2.75  105 for bovine SOD1 and 1.53  105 for human SOD1
(Inset). (E) The koff dependence on pH follows a titration curve with apparent
pKa values of 	2.5 and 12.5 at the acidic and basic ends of the pH range
respectively. The lines have slopes of 1 and 1 (Eq. 2).
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of aggregation as a function of the degree of dimer dissociation at
pH 3.5. Based on a Kd 1 M, as determined by AUC (Table 1),
a 30-M SOD1 solution was 84% (25 M) dimeric, whereas a 1-M
solution was 39% (0.39 M) dimeric, corresponding to a 60-fold
excess of dimer in the 30-M sample compared with the 1-M
sample.
SOD1 (30 M) eluted predominantly as a dimer (elution volume
16.5 ml; Fig. 6A) on incubation for 40 min (Fig. 3A Top). Forty
minutes was sufficient for the establishment of equilibrium because
the dimer dissociation has a half-time of 600 s at this pH (Fig. 2B).
The elution profiles remained largely unaltered for 48 h (Fig. 3A
Middle and Bottom), and there was little aggregation because nearly
identical peak heights and areas in the UV-absorbance profiles
were obtained after incubation. This finding agreed with AUC
results in which 30 M SOD1 gave nearly identical UV-absorbance
signals and apparent Mm estimates (Table 1). After 48 h, most of the
protein remained dimeric or monomeric (Fig. 3A), and 	10% was
aggregated.
Relatively rapid aggregation occurred with 1 M SOD1 (Fig.
3B). After 40 min of incubation, the protein eluted in a broad peak
centered at 17.2 ml, corresponding to a 40:60 mixture of dimer and
monomer, as expected from a Kd of 1 M. The rate of aggregation
was initially rapid, and after 24 and 48 h 60% of the protein was
aggregated. The aggregation rate is expected to decrease markedly
with time, and the failure to observe a significant increase in the
fraction of aggregated protein at 48 h can be attributed to exper-
imental error. These results show that at a given concentration,
SOD1 aggregation is proportional to the fraction of monomer,
rather than dimer, in solution.
Rapid Oligomerization of SOD1 Occurs Under Conditions Where Metals
Are Lost Irreversibly. Because the chelation of metals is known to
destabilize SOD1 (26) and promote aggregation (24), we pos-
tulated that the reactive species for aggregation is the apo-
monomer. To test this notion, we determined the time course of
aggregation of 30 M SOD1 under conditions where metal loss
was made irreversible by dialysis against metal-free buffer.
Dialysis at pH 3.6 results in a rapid loss of 95% of the Zn (31),
and the unbound metals were expected to be removed rapidly
because we had found that the loss of cupric acetate from the
dialysis bag has a concentration-independent (range from 100
M to 10 mM) half-time of 10 min under the conditions of the
experiment (data not shown). A substantial amount of aggre-
gation was expected if the loss of metals from SOD1 induced
formation of a species that was aggregation-competent.
During incubation under dialysis conditions the amount of dimer
rapidly decreased, the degree of dimer dissociation increased, and
the protein was almost completely aggregated in 21 h (Fig. 3D).
Electron micrographs of the aggregates obtained by negative
staining show that they have fibrillar morphology (Fig. 3D Inset).
Despite the fact that the dimer concentration decreased monoton-
ically, the monomer concentration initially increased and subse-
quently gradually decreased (Fig. 3E), indicating that under dialysis
conditions, dimer dissociation is coupled to metal loss and aggre-













where Dholo, Mholo, Mapo, and A are the holo-dimer, holo-monomer,
Zn-free monomer, and aggregate, respectively. In contrast, in AUC
studies described above, the dominant species after incubation
remained Dholo and Mholo, and there was no detectable aggregation.
The coincidence between the increase in Mapo and the increased
rate of aggregation shows that the apo-monomer is the reactive
Fig. 3. Kinetics of aggregation of SOD1. (A) Aggregation at 30 M. SOD1 elution profiles were obtained at initial time and at 24 and 48 h by immunostaining
dot blots and UV absorbance (solid lines). The profiles were normalized according to the fraction with the highest signal intensity, and the monomer is more
pronounced in the dot-blot elution profile. Aggregate is defined as the protein not eluting as dimer or monomer. (B) Aggregation at 1 M. SOD1 was detected
by immunobloting column fractions with Gaussian fits to the spot-intensity profile. (C) Dot blots showing the elution profile at 30 and 1 M before and after
incubation. The fractions corresponding to the dimer and monomer at 30 M were diluted 30-fold to ensure linearity of signal. (D) Time course of 30 M SOD1
under dialysis conditions. (Inset) An image of the fibrilar product after 21 h, obtained by negative staining electron microscopy. (E) Fit of the model in Eq. 3 to
the results obtained in D. The continuous curves are obtained from numerical simulations with the optimized rate constants. (F) Predicted aggregation profiles
with 30 and 1 M using the parameters derived in E. The predicted fraction of aggregates in 30 and 1 M SOD1 after 48 h was 14% and 63%, respectively, in
close agreement with the experimentally measured values in A and B.







species for this process. Moreover, because the apo-monomer
accumulated before aggregation, it is concluded that the oligomer-
ization of apo-monomers is the rate-limiting step in Eq. 3.
For a more detailed characterization of SOD1 aggregation at pH
3.5, the rate constants in the reaction sequence Eq. 3 were obtained.
The value koff  1  103 s1 (Fig. 2B) was determined from SPR,
and kon 103 M1s1 was calculated from Kd  1 M. The
constants km
  1.2  104 s1, km
  5.2  104 M1s1, and kagg
 0.1  103 M1s1 were estimated from the observed kinetics of
dialysis-induced aggregation (Supporting Text). The estimated value
of km
  1.2  104 s1 agrees well with the previously measured
km
  4.2  104 s1 (31) for the loss of Zn from SOD1 at pH 3.6
(half-time of 27 min at 20°C). The differential master equations
corresponding to Eq. 3 were solved numerically (Supporting Text),
and the above rate constant estimates were refined, fitting to the
observed time profile of dialysis-induced aggregation (Fig. 3E). The
values that best account for the experimental results are: koff  3 
103 s1, kon  1.6  103 M1s1, km
  1  103 s1, km
  9.8 
103 M1s1, and kagg  1  103 M1s1. The rate constant values
were found to be robust within an order of magnitude: the fit
worsened dramatically on variations in rate constants greater than
an order of magnitude. In accord with the above rate constants,
which predict 12% aggregation in 30 M SOD1 after 24 h under
nondialysis conditions, we had found little aggregation (Fig. 3A).
Similarly, 14% and 63% aggregation is predicted at 30 and 1 M
in 48 h (Fig. 3F), which is in good agreement with the observed
values of 10% and 60%, respectively.
Discussion
To create amyloidogenic conditions under which the aggregation of
proteins can be induced readily, acidic conditions are routinely
used. For example, amyloidogenic intermediates of transthyretin,
2-microglobulin, prion, and lysozyme have been characterized at
pH 4.5 (35), pH 3.6 (36), pH 4.4–6 (37), and pH 2 (38), respectively.
Under conditions where SOD1 aggregation is experimentally ac-
cessible (pH 3.5), we have demonstrated an aggregation pathway in
which the dimer dissociates, metal is lost from the resultant
monomer, and the apo-monomers aggregate in a rate-limiting step.
The absence of any discontinuity in the rate of dimer dissociation
when the pH is reduced from 7.8 to 3.5 (Fig. 2E) provides evidence
that the same pathway holds at physiological pH, but at a drastically
reduced rate (Fig. 4). Similarly, the pH effects on the metal content
of human, bovine, and yeast WT and yeast mutant SOD1 (in the
range of pH 3 to 9) have been shown to be continuous, reversible,
and related to conformational changes in the protein (39), further
indicating that the holo- and apo-monomer equilibrium is also a
representative property of the protein.
The Sequence of Events and the Reactive Species in the Aggregation
of SOD1. To identify the sequence of events in the aggregation
reaction and the aggregation-prone reactive species, we character-
ized the concentration and metal-content dependence of SOD1
aggregation. For the former, conditions such that there was a
preponderance of either dimer or monomer were chosen, and the
profiles of the initial phase of SOD1 aggregation under these
conditions were compared. Total SOD1 concentrations of 30 and
1 M were chosen so that at equilibrium there is an 60-fold excess
of dimer at the higher concentration. If aggregation depends on a
bimolecular dimer–dimer reaction, a 3,600-fold greater aggregation
rate is expected at the higher concentration. Similarly, a 60-fold
greater aggregation rate is expected if a unimolecular isomerization
reaction, i.e., a conformation change in dimer, leading to an
aggregation-competent dimeric species, is rate-limiting. In stark
contrast, we found rapid aggregation at the lower of the two
concentrations, demonstrating that the dimer is not the reactive
species for aggregation. The amount of aggregate at time t is
kagg[M]2t, where [M] is the concentration of the aggregating species.
Although there is an 8-fold excess of the total monomer at 30 M
compared with 1 M, the concentration of the aggregating apo-
monomer is 3-fold higher at 30 M. The total protein concentration
is 30-fold higher in the 30-M sample and therefore, the fraction of
the protein in aggregates, fagg  kagg[M]2tcT, where cT is the total
concentration of the protein, will be higher at 1 M than at 30 M,
in agreement with the data in Fig. 3C.
To ascertain whether the reactive species for aggregation is a
metal-bound or metal-free monomer, aggregation kinetics were
determined with 30 M SOD1 under conditions where the loss of
metals from the protein was irreversible. We found that the dimer
concentration rapidly decreased, whereas the monomer concentra-
tion initially increased and then gradually decreased (Fig. 3E), and
that aggregation into a fibrillar product was nearly complete in 21 h.
A comparison with the aggregation kinetics of 30 M SOD1 in the
absence of dialysis (Fig. 3A) shows that the monomeric species
appearing under dialysis conditions is the apo-monomer. These
findings constitute direct evidence that aggregation occurs via an
apo-monomer intermediate. The finding that the apo-monomer
accumulated before aggregation shows that the final assembly step
is rate-limiting in the reaction Eq. 1. The mechanism in Eq. 1 is
minimal because the final step leading to fibril formation is likely
to be a complex multistep process, possibly involving higher-order
nuclei and oligomers (40, 41). kagg is an apparent second-order rate
constant that is a convolution of these underlying higher-order
reactions. Also, kagg  103 M1s1 is significantly smaller than ex-
pected for a diffusion-controlled reaction, kdiff  106 to 109 M1s1,
further suggesting that additional steps that reduce the effective
concentration of the aggregating species, such as a rate-limiting
conformational change in the monomer or formation of oligomeric
nuclei, occur downstream of the apo-monomer formation.
The monomer intermediate in the proposed mechanism was
recently observed for oxidized SOD1 aggregation (42) and the A4V
FALS mutant (43). Also, mutants that cause monomerization of
the homotetrameric protein transthyretin (44) were found to ag-
gregate rapidly and were cytotoxic. The dissociation of multimeric
proteins into their monomeric subunits, followed by misfolding and
oligomerization, may be a general theme in the amyloidosis of
proteins.
The Thermodynamics and Kinetics of Dimer Dissociation and SOD1
Stability. The low value of Kd 1.6  1010 M at pH 7.8 reported
here is consistent with previous studies showing the remarkable
stability of the SOD1 dimer. The dimer retains its native 32-kDa Mm
Fig. 4. A scheme for the aggregation of SOD1. The more rapid aggregation
at pH 3.5 compared with pH 7.8 results from the increased Kd and koff values
at pH 3.5. Exposure to low pH decreases the stability of SOD1 by 5.2 (
13.5–8.3) kcalmol, whereas the dissociation barrier is reduced by 2 kcal
mol. At pH 3.5, the dissociation free energy of Zn from SOD1 monomer, Mholo,
is 9.6 kcalmol. In the minimal reaction sequence (Eq. 1), the apo-monomers,
Mapo, aggregate to form insoluble fibrils; this step is the rate-limiting step for
aggregation.
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in 8 M urea for 72 h at 25°C (45) and is active in 4% SDS (46). This
stability was also seen in pulse–chase studies, showing that the
protein has a relatively long (20–78 h) half-life in cells (12, 47, 48).
The Kd  1.6  1010 M (pH 7.8, 37°C) corresponds to a free
energy, Gd  13.5 kcalmol, for the dimer dissociation reaction:
D o 2M. Consistent with our estimate, a three-state fit to SOD1
unfolding (32) of the homologous human SOD1 (pH 7.4, 20°C)
gave: D o 2M o U; Gd  12.5 kcalmol and Gm  8
kcalmol, where U is the unfolded state and Gm is the free energy
of unfolding of both monomers. The total stability of SOD1 (Gd
 Gm) is 20.5 kcalmol (32), and the dimer dissociation free
energy represents the largest contribution to the stability of the
protein. Therefore, conditions that lead to aggregation must de-
stabilize the dimer andor reduce the dissociation barrier. In accord
with this scenario, we found that the rate and equilibrium constants
for dimer dissociation are enhanced 30-fold and 6  103-fold at pH
3.5 compared with pH 7.8. These values imply that low pH reduces
the dimer dissociation barrier by 2.0 kcalmol, whereas the dimer
stability is reduced by 5.2 ( 13.5–8.3) kcalmol (Fig. 4). Thus, the
rarity and the late age of onset of ALS may occur because under
physiological conditions the Kd and koff are 6,000- and 30-fold
smaller, and the H concentration expected to induce metal loss is
10,000-fold smaller, compared with pH 3.5. The effect of factors
related to aging, such as the decreased efficacy of chaperone-
mediated proteosomal degradation (23), is likely to increase the
demetallation andor the dimer dissociation in vivo.
A Model for the Effect of FALS Mutations on SOD1 Aggregation. There
is no discernable pattern in the primary, secondary, or tertiary
structure of FALS-associated SOD1 mutants, suggesting that they
affect a global property of the protein. We postulate that mutations
affect one or more steps in the multistep pathway for SOD1
aggregation, which suggests a unified framework to account for the
effect of FALS mutants on SOD1 aggregation (Fig. 4). Dimer
dissociation generates a monomeric form of SOD1, which loses its
metal(s) to generate the aggregation-competent species Mapo. We
have computationally estimated (unpublished results) that 70 of 75
known FALS-associated point mutants in SOD1 decrease the
dimer stability andor increase dissociation propensity. We propose
that mutant forms of SOD1 result in FALS because of one or more
of the following: (i) mutations destabilize the SOD1 dimer, result-
ing in higher than normal concentrations of Mholo and consequently
Mapo; (ii) mutations enhance the loss of metals from Mholo, possibly
by affecting the interaction with the copper chaperone CCS,
resulting in higher than normal concentrations of Mapo; and (iii)
SOD1 mutations reduce the barrier for fibril formation. In all cases,
the probability for forming protein aggregates is significantly in-
creased. Important questions concerning the role, if any, of aggre-
gates in the cell-specific biological origin of FALS, i.e., why the
aggregates are found only in motor neurons and the origin of
cytotoxicity in the disease, remain a formidable challenge.
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